Global Injectable Anticoagulants Market Research Report 2022
Summary
Market Analysis and Insights: Global Injectable Anticoagulants Market
The global Injectable Anticoagulants market size is projected to reach US$ 9907.8 million by 2028, from US$ 6667.5 million in 2021, at a CAGR of 5.60% during 2022-2028.
Low-Molecular-Weight Heparin (LMWH) accounting for 50.07% of the Injectable Anticoagulants global market in 2021, is projected to value US$ 5353.2 million by 2028, growing at a revised 6.64% CAGR in the forecast period. While VTE segment is altered to a 5.51% CAGR throughout this forecast period.
China Injectable Anticoagulants market size is valued at US$ 1102.7 million in 2021, while the North America and Europe Injectable Anticoagulants are US$ 2111.3 million and US$ 2283.7 million, severally. The proportion of the North America is 31.67% in 2021, while China and Europe are 16.54% and 34.25% respectively, and it is predicted that China proportion will reach 24.13% in 2028, trailing a CAGR of 11.44% through the analysis period. As for the Europe Injectable Anticoagulants landscape, Germany is projected to reach US$ 680.3 million by 2028 trailing a CAGR of 2.55% over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Anticoagulants market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Anticoagulants market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Anticoagulants market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Anticoagulants market.
Global Injectable Anticoagulants Scope and Market Size
Injectable Anticoagulants market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals
Segment by Type
LMWH
Unfractionated Heparin
Fibrinolytics
Other
Segment by Application
VTE
ACS/MI
AF
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
GCC
Turkey
South Africa
Rest of MEA
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook